CapitalBio and VigeneTech Announce the Launch of a Fully Integrated Microarray Solution Platform
Product News Aug 03, 2009
CapitalBio Corp., a developer and marketer of diagnostic biochips and advanced microarray instrument systems, in collaboration with VigeneTech Inc., developers of novel image analysis, automation, and instrumentation software, now offer a platform that combines the performance and “one-click” automation of the MicroVigene™ image analysis suite with the long established performance of CapitalBio’s LuxScan™ microarray scanners.
According to manufacturers, the LuxScan™ system with MicroVigene™ is well-suited for diagnostic and high-throughput DNA, protein, antibody, and miRNA array applications. The embedded image acquisition control, combined with the synchronized image analysis of the LuxScan/ MicroVigene platform is designed to offer speed, sensitivity, and image data of accuracy.
VigeneTech’s customized quality control processes and flexible architecture ensure robust automation, while maintaining the flexibility to meet the quality and performance demands of clinical and pre-clinical array applications, the company claims.
“The MicroVigene software from VigeneTech bring a new dimension to the analysis possibilities realizable with LuxScan microarray scanners, opening up a suite of advanced applications for protein analysis, DNA analysis and cell analysis” - noted Dr. Jing Cheng, CEO and Founder of CapitalBio.
“The LuxScan scanners have a wide depth of field which can capture accurate images from different types of microarrays and from tissue arrays. The combination of these scanning advantages with MicroVigene software provides enhanced analysis possibilities. This fully customized application brings image analysis to a new level of control. Irregular spots and offset spots are all found easily and then analyzed with the highest accuracy.”